688297:SSEAvic (Chengdu) UAS Co., Ltd. Class A Analysis
Data as of 2026-09-07 - not real-time
CN¥43.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At ¥43.49, AVIC (Chengdu)UAS Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has gained 9.2% over the past 30 days. RSI sits at 67.0, which reads as approaching overbought, and MACD momentum is bullish. Price has been bracketed by support at ¥38.01 and resistance at ¥45.40.
The shares look overvalued, trading on 255.8 times earnings above a sector average of 28.5. Analyst price targets sit 15.7% above the current price. Revenue is growing at 422.2% on a 2.7% profit margin. The 0.47% dividend yield looks stretched against payout coverage.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 32.9%, a beta of -0.16 and a maximum drawdown of 40.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
The shares look overvalued, trading on 255.8 times earnings above a sector average of 28.5. Analyst price targets sit 15.7% above the current price. Revenue is growing at 422.2% on a 2.7% profit margin. The 0.47% dividend yield looks stretched against payout coverage.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 32.9%, a beta of -0.16 and a maximum drawdown of 40.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
Top Market Events
Yahoo Finance10monAVIC Chengdu UAS Co., Ltd. 688297.SS Reveal insider sentiment with alternative data that tracks buy...Barron's2yAVIC Chengdu UAS Co. Ltd. AAvic Chengdu UAS Co., Ltd. engages in design, development, manufacturing, sales,...Investing9monAvic Chengdu Uas Co LtdAvic Chengdu Uas's latest twelve months p/e ratio is 475.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 46.45
- MACD momentum is positive
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 255.8 versus sector average of 28.5
- Dividend yield of 0.47% looks stretched against payout coverage
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 255.8 versus sector average of 28.5
- Dividend yield of 0.47% looks stretched against payout coverage
- Analyst targets imply +15.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth422.20%
Profit Margin2.65%
P/E Ratio255.8
ROE1.98%
ROA0.23%
Debt/Equity2.68
P/B Ratio5.3
Op. Cash FlowCN¥82.6M
Free Cash FlowCN¥95.1M
Industry P/E28.5
Technical Analysis
TrendBearish
RSI67.0
SupportCN¥38.01
ResistanceCN¥45.40
MA 20CN¥40.43
MA 50CN¥40.61
MA 200CN¥46.45
MACDBullish
VolumeIncreasing
Fear & Greed Index94.11
Valuation
Fair ValueCN¥9.40
Target PriceCN¥50.32
Upside/Downside15.70%
GradeOvervalued
TypeGrowth
Dividend Yield0.47%
Risk Assessment
Beta-0.16
Volatility32.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.